Manulife (Manufacturers Life Insurance)
ELDN icon

Manulife (Manufacturers Life Insurance)’s Eledon Pharmaceuticals ELDN Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio ELDN Stock Details ELDN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$84.5K Buy
21,451
+1,017
+5% +$3.7K ﹤0.01% 2777
2026
Q1 		$62.9K Buy
+20,434
New +$48.1K ﹤0.01% 2707
2025
Q4 		– Sell
-19,072
Closed -$49.4K – 2877
2025
Q3 		$49.4K Buy
+19,072
New +$55.8K ﹤0.01% 2883
2017
Q2 		– Sell
-50
Closed -$7K – 4379
2017
Q1 		$7K Hold
50
– – ﹤0.01% 3711
2016
Q4 		$8K Buy
50
+49
+4,900% +$9.39K ﹤0.01% 3822
2016
Q3 		$0 Hold
1
– – ﹤0.01% 4301
2016
Q2 		$1K Sell
1
-10
-91% -$11K ﹤0.01% 4091
2016
Q1 		$10K Buy
11
+10
+1,000% +$9.82K ﹤0.01% 3630
2015
Q4 		$1 Sell
1
-11
-92% -$19.2K ﹤0.01% 3876
2015
Q3 		$21 Buy
12
+11
+1,100% +$22.7K ﹤0.01% 3442
2015
Q2 		$2 Buy
+1
New +$1.94K ﹤0.01% 3820

Other funds holding ELDN

BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DCM
Defilade Capital Management Emeryville, California $747M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $60.8B AUM 42.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CCM
Catalio Capital Management New York $532M AUM 166.55% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ZP
Zimmer Partners New York $4.34B AUM 22.78% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s ELDN Position: Q2 2026 in Review

Manulife (Manufacturers Life Insurance) increased its Eledon Pharmaceuticals (ELDN) stake by 5% in Q2 2026, buying an estimated $3.7K and bringing the position to 21,451 shares worth $84.5K. The position accounts for ﹤0.01% of the portfolio, ranked #2777.

Manulife (Manufacturers Life Insurance) first reported a position in ELDN in Q2 2015 and has held it in 11 quarters since. 160 funds tracked by Wall St. Rank hold ELDN as of Q2 2026.

  • Manulife (Manufacturers Life Insurance) held 21,451 shares of Eledon Pharmaceuticals worth $84.5K as of Q2 2026.
  • Manulife (Manufacturers Life Insurance) bought 1,017 Eledon Pharmaceuticals shares in Q2 2026, an estimated $3.7K.
  • Eledon Pharmaceuticals made up ﹤0.01% of Manulife (Manufacturers Life Insurance)'s portfolio in Q2 2026, its #2777 holding.
  • Manulife (Manufacturers Life Insurance) first reported a position in Eledon Pharmaceuticals in Q2 2015 and has held it in 11 quarters since.
  • 160 funds tracked by Wall St. Rank held Eledon Pharmaceuticals as of Q2 2026.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q2 2026, filed 14 Aug 2026.